Search for Clinical Trial Results
Buerger Disease - 9 Studies Found
Status | Study |
Completed |
Study Name: Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Buerger's Disease Condition: Buerger's Disease Date: 2011-02-17 Interventions: Biological: RNL-Vascostem® Other Name: Autologous adipose tissue derived mesenchymal stem cells |
Completed |
Study Name: A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease Condition:
Date: 2011-11-27 Interventions:
|
Withdrawn |
Study Name: A Clinical Trial to Study the Efficacy and Safety of Stempeucel® in Patients With CLI Due to Buergers Disease Condition: Critical Limb Ischemia Due to Buerger's Disease Date: 2017-01-23 Interventions: Biological: Stempeucel(R) Ex vivo cultured adult bone marrow derived allogeneic mesenchymal stem cells |
Completed |
Study Name: Treatment of Thromboangiitis Obliterans (Buerguer's Disease) With Bosentan Condition: Thromboangiitis Obliterans Date: 2011-10-05 Interventions: Drug: Bosentan Bosentan therapy consisted of a month's treatment with 62.5 mg bid orally administered. D |
Completed |
Study Name: ADDICTAO: Psychological and Addictive Profile of Patients With Buerger's Disease Condition:
Date: 2010-02-05 |
Completed |
Study Name: Contrast Enhanced Ultrasound and Muscle Condition:
Date: 2014-04-29 Interventions: Other: contrast echographie with hexafluorur of sulfur Echography of contrast after injection of product |
Completed |
Study Name: Safety and Efficacy Study of Autologous BM-MNC Processed by Two Methods for Treating Patients With Chronic Limb Ischemia Condition:
|
Recruiting |
Study Name: Purified CD34+ Cells Versus Peripheral Blood Mononuclear Cells in Treatment of Critical Limb Ischemia Condition:
|
Completed |
Study Name: Autologous Endothelial Progenitor Cells (EPCs) From Peripheral Blood in the Treatment of Critical Limb Ischemia Condition: Critical Limb Ischemia Date: 2012-02-14 Interventions: Other: Endothelial progenitor cells intramuscular implant After marrow stimulation the CD133+ cell count |